The Journal of Practical Medicine >
The advanced progress on the relationship between hyperuricemia and acute myocardial infarction
Received date: 2023-09-04
Online published: 2024-03-26
Acute myocardial infarction （AMI） is one of the leading causes of cardiac death. The percutaneous coronary intervention （PCI） can improve the prognosis of AMI patients， but the overall prognosis of AMI patients is not optimistic. Hyperuricemia has become one of the risk factors for cardiovascular diseases. The role of hyperuricemia in the occurrence， development and prognosis of AMI has attracted increasing attention. This article reviews the research progress on the relationship between hyperuricemia and AMI.
Jianlong SHENG , Ni′na. LIU . The advanced progress on the relationship between hyperuricemia and acute myocardial infarction[J]. The Journal of Practical Medicine, 2024 , 40(5) : 727 -730 . DOI: 10.3969/j.issn.1006-5725.2024.05.023
| 1 | ANDERSON J L， MORROW D A. Acute Myocardial Infarction［J］. N Engl J Med， 2017， 376（21）：2053-2064. doi:10.1056/nejmra1606915 |
| 2 | BORGHI C， DOMIENIK-KAR?OWICZ J， TYKARSKI A，et al.Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk： 2021 update［J］. Cardiol J， 2021，28（1）：1-14. doi:10.5603/cj.a2021.0001 |
| 3 | TALPUR A S， FATTAH A， HEWADMAL H，et al. Asymptomatic Hyperuricemia as an Independent Risk Factor for Myocardial Infarction in Adult Population： A Four-Year Follow-Up Study［J］. Cureus， 2023，15（2）：e34614. |
| 4 | KIM S， HWANG B H， LEE K Y， et al. High Uric Acid Levels in Acute Myocardial Infarction Provide Better Long-Term Prognosis Predictive Power When Combined with Traditional Risk Factors［J］. J Clin Med，2022， 11（19）：5531. doi:10.3390/jcm11195531 |
| 5 | HAJIZADEH R， GHAFFARI S， SALEHI R， et al. Association of serum uric acid level with mortality and morbidity of patients with acute ST-elevation myocardial infarction［J］. J Cardiovasc Thorac Res，2016，8（2）：56-60. doi:10.15171/jcvtr.2016.11 |
| 6 | ALVAREZ-LARIO B， MACARRON-VICENTE J. Uric acid and evolution［J］.Rheumatology， 2010，49（11）：2010-2015. doi:10.1093/rheumatology/keq204 |
| 7 | 黄叶飞，杨克虎，陈澍洪，等. 高尿酸血症/痛风患者实践指南［J］. 中华内科杂志，2020，59 （7）：519-527. doi:10.3760/cma.j.cn112138-20200505-00449 |
| 8 | SONG P， WANG H， XIA W， et al. Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China［J］. Sci Rep，2018，8（1）：4314. doi:10.1038/s41598-018-22570-9 |
| 9 | CHEN-XU M， YOKOSE C， RAI S K， et al. Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends： The National Health and Nutrition Examination Survey， 2007-2016［J］. Arthritis Rheumatol， 2019，71（6）：991-999. doi:10.1002/art.40807 |
| 10 | LIU R， HAN C， WU D， et al. Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014： A Systematic Review and Meta-Analysis［J］. Biomed Res Int， 2015，2015：762820. doi:10.1155/2015/762820 |
| 11 | COLANTONIO L D， SAAG K G， SINGH J A， et al. Gout is associated with an increased risk for incident heart failure among older adults： the REasons for Geographic And Racial Differences in Stroke （REGARDS） cohort study［J］. Arthritis Res Ther， 2020，22（1）：86. doi:10.1186/s13075-020-02175-2 |
| 12 | BOARDMAN N T， FALCK A T， LUND T， et al. Human concentrations of uric acid scavenges adaptive and maladaptive reactive oxygen species in isolated rat hearts subjected to ischemic stress［J］. Can J Physiol Pharmacol， 2020，98（3）：139-146. doi:10.1139/cjpp-2019-0024 |
| 13 | ZHOU Z， ZHONG S， LIANG Y， et al. Serum Uric Acid and the Risk of Dementia： A Systematic Review and Meta-Analysis［J］. Front Aging Neurosci， 2021，13：625690. doi:10.3389/fnagi.2021.625690 |
| 14 | HONG Q， WANG L， HUANG Z，et al. High Concentrations of Uric Acid and Angiotensin II Act Additively to Produce Endothelial Injury［J］. Mediators Inflamm， 2020，2020：8387654. doi:10.1155/2020/8387654 |
| 15 | TIAN X， ZUO Y， CHEN S， et al. Associations between changes in serum uric acid and the risk of myocardial infarction［J］. Int J Cardiol， 2020，314：25-31. doi:10.1016/j.ijcard.2020.03.083 |
| 16 | KU?MA ?， KULIKOWSKA A， KURASZ A， et al. The effect of serum uric acid levels on the long-term prognosis of patients with non-ST-elevation myocardial infarction［J］. Adv Clin Exp Med， 2020，29（11）：1255-1263. doi:10.17219/acem/127145 |
| 17 | KAYA M G， UYAREL H， AKPEK M， et al. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention［J］.Am J Cardiol， 2012，109（4）：486-491. doi:10.1016/j.amjcard.2011.09.042 |
| 18 | LAZZERI C， VALENTE S， CHIOSTRI M， et al. Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI： its prognostic role and relation with inflammatory markers： a single center experience［J］. Int J Cardiol， 2010，138（2）：206-209. doi:10.1016/j.ijcard.2008.06.024 |
| 19 | LAZZERI C， VALENTE S， CHIOSTRI M， et al. Uric acid in the early risk stratification of ST-elevation myocardial infarction［J］. Intern Emerg Med， 2012，7（1）：33-39. doi:10.1007/s11739-011-0515-9 |
| 20 | WANG A， TIAN X， WU S， et al. Metabolic Factors Mediate the Association Between Serum Uric Acid to Serum Creatinine Ratio and Cardiovascular Disease［J］. J Am Heart Assoc， 2021，10（23）：e023054. doi:10.1161/jaha.121.023054 |
| 21 | LIU W， YU W， XIE D， et al. High Uric Acid Promotes Atherosclerotic Plaque Instability by Apoptosis Targeted Autophagy［J］. J Atheroscler Thromb， 2023， 30（9）：1176-1186. doi:10.5551/jat.63645 |
| 22 | CHENG X， LIU T， MA L， et al.Prothrombotic effects of high uric acid in mice via activation of MEF2C-dependent NF-κB pathway by upregulating let-7c［J］. Aging （Albany NY）， 2020，12（18）：17976-17989. doi:10.18632/aging.103540 |
| 23 | KOBAYASHI N， HATA N， TSURUMI M， et al. Relation of Coronary Culprit Lesion Morphology Determined by Optical Coherence Tomography and Cardiac Outcomes to Serum Uric Acid Levels in Patients With Acute Coronary Syndrome［J］. Am J Cardiol，2018，122（1）：17-25. doi:10.1016/j.amjcard.2018.03.022 |
| 24 | MANDURINO-MIRIZZI A， CORNARA S， SOMASCHINI A， et al. Elevated serum uric acid is associated with a greater inflammatory response and with short- and longterm mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention［J］. Nutr Metabol Cardiovasc Dis， 2021，31（2）：608-614. doi:10.1016/j.numecd.2020.10.020 |
| 25 | MANDURINO-MIRIZZI A， CRIMI G， RAINERI C， et al. Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention［J］. J Cardiovasc Med （Hagerstown）， 2018，19（5）：240-246. doi:10.2459/jcm.0000000000000634 |
| 26 | HU X， YANG X， LI X， et al. Elevated uric acid is related to the no-/slow-reflow phenomenon in STEMI undergoing primary PCI［J］. Eur J Clin Invest， 2022，52（4）：e13719. doi:10.1111/eci.13719 |
| 27 | 中华医学会内分泌学分会. 中国高尿酸血症与痛风诊疗指南 （2019）［J］. 中华内分泌代谢杂志， 2020，36（1）：1-13 |
| 28 | MACKENZIE I S， HAWKEY C J， FORD I， et al. Allopurinol versus usual care in UK patients with ischaemic heart disease （ALL-HEART）： a multicentre， prospective， randomised， open-label， blinded-endpoint trial［J］. Lancet， 2022，400（10359）：1195-1205. doi:10.1016/s0140-6736(22)01657-9 |
| 29 | HROMADKA M， OPATRNY J， MIKLIK R， et al. Uricemia in the acute phase of myocardial infarction and its relation to long-term mortality risk［J］. J Comp Eff Res， 2021，10（12）：979-988. doi:10.2217/cer-2021-0082 |
| 30 | AL-ABDOUH A， KHAN S U， BARBARAWI M， et al. Effects of Febuxostat on Mortality and Cardiovascular Outcomes： A Systematic Review and Meta-Analysis of Randomized Controlled Trials［J］. Mayo Clin Proc Innov Qual Outcomes， 2020，4（4）：434-442. doi:10.1016/j.mayocpiqo.2020.04.012 |
| 31 | MACKENZIE I S， FORD I， NUKI G， et al. Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout （FAST）： a multicentre， prospective， randomised， open-label， non-inferiority trial［J］. Lancet， 2020，396（10264）：1745-1757. doi:10.1016/s0140-6736(20)32234-0 |
| 32 | 逄成章，刘文彬，金小宝. 基于疾病基因表达谱和药物转录组的抗高尿酸血症药物“重定位”［J］. 实用医学杂志， 2022，38（22）：2838-2844. |
| 33 | DOEHNER W， ANKER S D， BUTLER J， et al. Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction： the EMPEROR-reduced trial［J］. Eur Heart J， 2022，43（36）：3435-3446. doi:10.1093/eurheartj/ehac320 |
| 34 | CASIGLIA E， TIKHONOFF V， VIRDIS A， et al. Serum uric acid and fatal myocardial infarction： detection of prognostic cut-off values： The URRAH （Uric Acid Right for Heart Health） study［J］. J Hypertens， 2020，38（3）：412-419. doi:10.1097/hjh.0000000000002287 |
| 35 | 王贤方，刘志东，张园，等. 南方汉族人群ABCG2 rs2231142和SLC2A9 rs3733591单核苷酸多态性与高尿酸血症及心血管危险因素的相关性［J］. 实用医学杂志， 2023，39（7）：875-880. |
/
| 〈 |
|
〉 |